Pascal Wehrlé

505 total citations
23 papers, 399 citations indexed

About

Pascal Wehrlé is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Pascal Wehrlé has authored 23 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Pascal Wehrlé's work include Drug Solubulity and Delivery Systems (8 papers), Advanced Drug Delivery Systems (6 papers) and Scientific Measurement and Uncertainty Evaluation (3 papers). Pascal Wehrlé is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Advanced Drug Delivery Systems (6 papers) and Scientific Measurement and Uncertainty Evaluation (3 papers). Pascal Wehrlé collaborates with scholars based in France, Italy and United States. Pascal Wehrlé's co-authors include Giovanni Filippo Palmieri, Simon Benita, A. Stamm, Sante Martelli, Piera Di Martino, Pierre Goldbach, S. Martelli, Christiane Damgé, Nathalie Ubrich and Maurice Hoffman and has published in prestigious journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and International Journal for Quality in Health Care.

In The Last Decade

Pascal Wehrlé

23 papers receiving 369 citations

Peers

Pascal Wehrlé
Jonathan K. Embleton United Kingdom
Pascal Wehrlé
Citations per year, relative to Pascal Wehrlé Pascal Wehrlé (= 1×) peers Jonathan K. Embleton

Countries citing papers authored by Pascal Wehrlé

Since Specialization
Citations

This map shows the geographic impact of Pascal Wehrlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Wehrlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Wehrlé more than expected).

Fields of papers citing papers by Pascal Wehrlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Wehrlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Wehrlé. The network helps show where Pascal Wehrlé may publish in the future.

Co-authorship network of co-authors of Pascal Wehrlé

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Wehrlé. A scholar is included among the top collaborators of Pascal Wehrlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Wehrlé. Pascal Wehrlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michel, Bruno, et al.. (2016). Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace. International Journal for Quality in Health Care. 28(6). 779–784. 10 indexed citations
2.
Martino, Piera Di, Sante Martelli, & Pascal Wehrlé. (2005). Evaluation of Different Fast Melting Disintegrants by Means of a Central Composite Design. Drug Development and Industrial Pharmacy. 31(1). 109–121. 26 indexed citations
3.
Çetin, Meltem, Yılmaz Çapan, İmran Vural, et al.. (2005). Preparation and characterization of bFGF and BSA-loaded microspheres. Journal of Drug Delivery Science and Technology. 15(5). 371–375. 6 indexed citations
4.
Wehrlé, Pascal, et al.. (2005). Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology. Drug Development and Industrial Pharmacy. 31(2). 179–189. 36 indexed citations
5.
Dragan, Ciprian, et al.. (2002). Power of Experimental Design Studies for the Validation of Pharmaceutical Processes: Case Study of a Multilayer Tablet Manufacturing Process. Drug Development and Industrial Pharmacy. 28(7). 841–848. 10 indexed citations
6.
Rey, H. Y., Karl Wagner, Pascal Wehrlé, & Peter Schmidt. (2000). Development of Matrix-Based Theophylline Sustained-Release Microtablets. Drug Development and Industrial Pharmacy. 26(1). 21–26. 15 indexed citations
7.
Palmieri, Giovanni Filippo, et al.. (1999). Methoxybutropate Microencapsulation by Gelatin-Acacia Complex Coacervation. Drug Development and Industrial Pharmacy. 25(4). 399–407. 24 indexed citations
8.
Palmieri, Giovanni Filippo, Pascal Wehrlé, & Sante Martelli. (1998). Interactions Between Lonidamine and β-or Hydroxypropyl-β-Cyclodextrin. Drug Development and Industrial Pharmacy. 24(7). 653–660. 15 indexed citations
9.
Benita, S., et al.. (1996). The use of factorial design in the development of nanoparticulate dosage forms. 73. 93–131. 1 indexed citations
10.
Palmieri, Giovanni Filippo, Pascal Wehrlé, & Sante Martelli. (1996). Drug release from compressed Eudragit RS 30D coated beads. Unicam Scientific Publications (University of Camerino). 6(2). 118–121. 3 indexed citations
11.
Wehrlé, Pascal, et al.. (1996). Sequential Statistical Optimization of a Positively-Charged Submicron Emulsion of Miconazole. Pharmaceutical Development and Technology. 1(1). 97–111. 19 indexed citations
12.
Palmieri, Giovanni Filippo, et al.. (1996). Gelatin-Acacia Complex Coacervation as a Method for Ketoprofen Microencapsulation. Drug Development and Industrial Pharmacy. 22(9-10). 951–957. 27 indexed citations
13.
Wehrlé, Pascal, et al.. (1995). The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design. European Journal of Pharmaceutics and Biopharmaceutics. 41(1). 19–26. 59 indexed citations
14.
Wehrlé, Pascal & A. Stamm. (1994). Statistical Tools for Process Control and Quality Improvement in the Pharmaceutical Industry. Drug Development and Industrial Pharmacy. 20(2). 141–164. 13 indexed citations
15.
Wehrlé, Pascal, Giovanni Filippo Palmieri, & A. Stamm. (1994). The Taguchi's Performance Statistic to Optimize Theophylline Beads Production in a High-Speed Granulator. Drug Development and Industrial Pharmacy. 20(18). 2823–2843. 11 indexed citations
16.
Wehrlé, Pascal, et al.. (1994). Evaluation of Spray-Drying as a Method to Prepare Microparticles for Controlled Drug Release. Drug Development and Industrial Pharmacy. 20(18). 2859–2879. 27 indexed citations
17.
Wehrlé, Pascal, et al.. (1993). Scaling-up of wet Granulation a Statistical Methodology. Drug Development and Industrial Pharmacy. 19(16). 1983–1997. 15 indexed citations
18.
Palmieri, Giovanni Filippo, et al.. (1993). Inclusion of Vitamin D2 in β-Cyclodextrin. Evaluation of Different Complexation Methods. Drug Development and Industrial Pharmacy. 19(8). 875–885. 9 indexed citations
19.
Wehrlé, Pascal, et al.. (1993). Response Surface Methodology: an Interesting Statistical Tool for Process Optimization and Validation: Example of Wet Granulation in a High-Shear Mixer. Drug Development and Industrial Pharmacy. 19(13). 1637–1653. 26 indexed citations
20.
Palmieri, Giovanni Filippo, et al.. (1992). Inclusion complexation of vitamin a palmitate with β-cyclodextrin in aqueous solution. Drug Development and Industrial Pharmacy. 18(19). 2117–2121. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026